Virological response to adefovir monotherapy and the risk of adefovir resistance

doi:10.3748/wjg.v17.i30.3526

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 17, Issue 30

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (3059)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-1) series, Tables (1-5) series.

Item

Count

PDF

297

HTML

2329

Figures (1-1)

197

Tables (1-5)

236

Sum=3059

Aug 14, 2011 (publication date) through Nov 25, 2024

Times Cited of This Article

Times Cited (5)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Brief Article

World J Gastroenterol. Aug 14, 2011; 17(30): 3526-3530
Published online Aug 14, 2011. doi: 10.3748/wjg.v17.i30.3526

Open in New Tab Full Size Figure Download Figure

Figure 1 Hepatitis B virus DNA levels after adefovir monotherapy. There were significant differences in the degree of Hepatitis B virus (HBV) DNA reduction between patients who developed adefovir resistance and those who did not (P value; ^aweek 12 = 0.027, ^bweek 24 = 0.002, ^cweek 48 = 0.002).

Citation: Sinn DH, Lee HI, Gwak GY, Choi MS, Koh KC, Paik SW, Yoo BC, Lee JH. Virological response to adefovir monotherapy and the risk of adefovir resistance. World J Gastroenterol 2011; 17(30): 3526-3530
URL: https://www.wjgnet.com/1007-9327/full/v17/i30/3526.htm
DOI: https://dx.doi.org/10.3748/wjg.v17.i30.3526